Breast Cancer Screening at 40: What the Latest U.S. Guidance Means for Women

Practical takeaway: In the United States, the U.S. Preventive Services Task Force (USPSTF) now recommends that women at average risk of breast cancer start getting mammograms every other year beginning at age 40 instead of 50. This change is aimed at detecting more cancers earlier, particularly among women in their 40s.

Breast cancer remains one of the most common cancers among women in the U.S. Screening does not prevent cancer, but it can find it earlier—often before symptoms appear—when treatment may be more effective.

What Changed in the National Recommendation?

The USPSTF, an independent panel of experts that reviews medical evidence, updated its guidance to recommend biennial (every two years) mammography for women ages 40 to 74 who are at average risk. Previously, routine screening was recommended starting at age 50, with individual decision-making advised for women ages 40 to 49.

This update was based on modeling studies and evidence showing that starting screening at 40 could reduce breast cancer deaths, particularly as rates of breast cancer in women in their 40s have increased in recent years.

The USPSTF recommendation applies to women and other people assigned female at birth who are at average risk. It does not apply to those with:

A known BRCA1 or BRCA2 gene mutation
A strong family history of breast cancer
A history of chest radiation at a young age
Previous breast cancer

Those individuals may need earlier or more frequent screening, often guided by specialty organizations such as the American Cancer Society and the American College of Obstetricians and Gynecologists (ACOG).

Why Start at Age 40?

According to data reviewed by the USPSTF and the National Cancer Institute, breast cancer incidence has been rising among women in their 40s. While the overall risk is still lower than in older age groups, cancers diagnosed at younger ages can sometimes be more aggressive.

Starting screening at 40 is estimated to prevent additional deaths compared with beginning at 50. However, screening in the 40s also increases the chance of:

False-positive results (being called back for more imaging when no cancer is present)
Short-term anxiety related to additional testing
Overdiagnosis (finding cancers that may never have caused harm)

These trade-offs are part of why shared decision-making with a clinician is still important.

What Is “Average Risk”?

Average risk means you do not have known genetic mutations linked to breast cancer, a strong family history, or other major risk factors.

Risk factors that may raise your risk include:

Older age
Dense breast tissue
Family history of breast or ovarian cancer
Early menstruation or late menopause
Obesity after menopause
Alcohol use

If you are unsure about your risk, your primary care clinician or OB-GYN can review your family history and determine whether you need earlier or additional screening, such as MRI.

What About Dense Breasts?

Dense breast tissue can make mammograms harder to interpret and is associated with a higher risk of breast cancer. The FDA now requires that mammography facilities notify patients about breast density.

However, evidence is still evolving on whether additional screening tests (such as ultrasound or MRI) improve outcomes for women with dense breasts who are otherwise at average risk. The USPSTF has said more research is needed in this area.

Insurance and Cost Considerations

Under the Affordable Care Act, most private insurance plans are required to cover USPSTF-recommended preventive services without cost-sharing. That typically includes screening mammograms that follow the Task Force guidance.

Medicare also covers screening mammograms for eligible beneficiaries. If you are uninsured or underinsured, programs supported by the CDC’s National Breast and Cervical Cancer Early Detection Program may offer low-cost or free screening in many states.

Symptoms to Watch For Between Screenings

Screening is important, but it does not replace paying attention to changes in your body. Contact a healthcare professional if you notice:

A new lump in the breast or underarm
Skin dimpling or thickening
Nipple discharge (especially if bloody)
Changes in breast shape or size
Persistent breast pain in one area

These symptoms do not always mean cancer, but they should be evaluated.

Whole-Person Health: Lifestyle and Risk

Screening is one part of breast health. Other preventive steps supported by public health guidance include:

Limiting alcohol intake
Maintaining a healthy weight
Regular physical activity
Breastfeeding when possible, which is associated with reduced risk

Oral health and overall inflammation are active areas of research, but at this time, routine dental care is recommended for general health rather than specifically for breast cancer prevention.

What This Means for Readers

If you are 40 or older and at average risk, routine mammography every two years is now the national evidence-based recommendation from the USPSTF.

If you are in your late 30s, now is a good time to talk with your clinician about your family history and personal risk factors so you have a plan in place when you turn 40.

Screening decisions are personal. The updated guidance aims to balance earlier detection with the realities of false positives and overdiagnosis. The right choice depends on your health history, values, and access to care.

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.

Sources

U.S. Preventive Services Task Force (USPSTF) – Breast Cancer: Screening Recommendation
National Cancer Institute (NCI) – Breast Cancer Screening Overview
Centers for Disease Control and Prevention (CDC) – What Is Breast Cancer Screening?
American College of Obstetricians and Gynecologists (ACOG) – Breast Cancer Screening Guidance
U.S. Food and Drug Administration (FDA) – Breast Density Notification Requirements